BN

Beteiligungsgesellschaft Neue Länder

Description

Beteiligungsgesellschaft Neue Länder.

Investor Profile

Beteiligungsgesellschaft Neue Länder has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Beteiligungsgesellschaft Neue Länder frequently co-invest with?

Co-Investments: 1
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 1
Deutsche Venture Capital
Europe, Bayern, Germany, München
Co-Investments: 1

What are some of recent deals done by Beteiligungsgesellschaft Neue Länder?

4SC

Planegg, Bayern, Germany

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.

BiopharmaBiotechnologyTherapeutics
Series BDec 12, 2000
Amount Raised: $15,030,853